You must be registered for Congress of Clinical Rheumatology East (CCRE) in order to attend this symposium.
Saturday, May 2, 2026
1:45 p.m. – 2:00 p.m. CT Registration & Refreshments
2:00 p.m.– 3:00 p.m. CT Meeting
Hilton Sandestin Beach Golf Resort & Spa
4000 Sandestin Boulevard South
Sandestin, FL 32550
Location: Emerald Ballrooms
PRESENTING FACULTY
 |
Judith A. James, MD, PhD Oklahoma Medical Research Foundation Executive Vice President and Chief Medical Officer Chair and Professor, Arthritis & Clinical Immunology Program University of Oklahoma Associate Vice Provost of Clinical & Translational Science Professor, Department of Medicine Oklahoma City, Oklahoma |
 |
Janet E. Pope, MD, MPH, FRCPC Professor of Medicine Division of Rheumatology University of Western Ontario London, Ontario, Canada |
PROGRAM OVERVIEW
This live symposium is designed to equip multidisciplinary clinicians and healthcare providers with the essential knowledge to navigate the transformative landscape of CAR T-cell therapy for systemic lupus erythematosus (SLE), particularly in the community setting. Participants will explore the underlying biological rationale and mechanisms of action of this novel therapeutic approach, as well as a rigorous evaluation of the latest clinical efficacy and safety data from emerging trials. Beyond the science, the program emphasizes practical application through shared decision-making (SDM) strategies, enabling clinicians to accurately identify appropriate candidates for CAR-T therapy, manage patient expectations, and provide expert counseling on the monitoring and mitigation of potential adverse events.
TARGET AUDIENCE
This activity is designed to meet the educational needs of US-based rheumatologists, rheumatology APPs (including NPs and PAs), nephrologists, and hematologists involved in the management of patients with SLE, especially in the community setting.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the rationale and mechanisms of action for CAR T-cell therapy in SLE
- Evaluate the clinical efficacy and safety data for emerging CAR-T therapies in SLE
- Employ SDM best practices to identify patients with SLE who may benefit from CAR-T therapy and counsel patients about AEs and treatment expectations
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
ACCME INNOVATION PARTNER DISCLAIMER
Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
